Receptor tyrosine kinase expression in human bone marrow stromal cells

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Bone marrow stromal cells (BMSCs) are crucial for bone formation and repair.
• The factors governing BMSC proliferation and differentiation remain largely unknown.
• Receptor tyrosine kinases (RTKs) are implicated in mesenchymal cell growth control.

Purpose of the Study:

• To investigate the expression and function of RTKs in human BMSCs (hBMSCs).
• To determine if RTK expression patterns correlate with the osteogenic potential of hBMSC clonal strains.

Main Methods:

• RT-PCR and degenerate oligonucleotides to identify expressed RTKs in hBMSCs.
• DNA sequencing to confirm RTK identity.
• Dose-dependent growth assays and tyrosine phosphorylation studies to assess RTK function.
• Semiquantitative RT-PCR to analyze RTK expression in clonal hBMSC strains.

Main Results:

• PDGF receptor (beta), EGF receptor, FGF receptor 1, and Axl were identified in hBMSCs.
• PDGF and EGF significantly enhanced hBMSC proliferation and induced receptor phosphorylation, indicating functional receptors.
• bFGF showed minimal effect on proliferation or phosphorylation.
• RTK expression levels varied among clonal hBMSC strains.
• Bone-forming strains showed higher average PDGF-receptor levels, while non-bone-forming strains had higher average EGF-receptor levels.

Conclusions:

• RTKs play a significant role in regulating hBMSC proliferation.
• Differential RTK expression patterns can potentially predict the osteogenic capacity of hBMSC clonal strains.
• Understanding RTK function provides insights into BMSC biology and potential therapeutic targets for bone regeneration.